Skip to main content

Use of Transcatheter Aortic Valve Replacement Up in Adults Younger Than 60

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 13, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, Feb. 13, 2024 -- For patients aged younger than 60 years, transcatheter aortic valve replacement (TAVR) is increasingly used and has overtaken surgical aortic valve replacement (SAVR), despite significantly better survival rates for SAVR, according to a study presented at the annual meeting of The Society of Thoracic Surgeons, held from Jan. 27 to 29 in San Antonio.

Joanna Chikwe, M.D., from the Smidt Heart Institute at Cedars-Sinai in Los Angeles, and colleagues examined clinical practice and midterm outcomes of TAVR and SAVR among patients aged younger than 60 years. Analyses included 2,360 patients who underwent TAVR and SAVR procedures (22.2 and 77.8 percent, respectively), with a median follow-up of 2.4 and 4.9 years, respectively.

The researchers found that the rate of TAVR increased significantly from 7 percent in 2013 to 62 percent in 2021 (annual percent change, 4.7 percent). The 30-day mortality was 0.2 versus 0.4 percent for SAVR versus TAVR. The primary outcome of five-year survival was significantly better for SAVR (98 versus 86 percent). SAVR and TAVR had a similar five-year cumulative incidence of reoperation (2.2 versus 3.8 percent), stroke (1.1 versus 0.8 percent), infective endocarditis (0.8 versus 0.4 percent), and heart failure readmission (1.9 versus 1.2 percent). The five-year survival rate was significantly better after SAVR in propensity score-matched patients (98 versus 88 percent; hazard ratio, 2.5); no significant difference was seen in the cumulative incidence of secondary outcomes.

"We were surprised there appears to be near equipoise in terms of procedure selection, with patients and clinicians opting for procedures against the 2020 guidelines," coauthor Jad Malas, M.D., also from Cedars-Sinai, said in a statement.

Press Release

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Noninvasive Imaging Aids Selection of Stenosis Patients Needing Revascularization Procedure

WEDNESDAY, April 24, 2024 -- Computed tomography fractional flow reserve (CT-FFR) improves assessment of vessel blockages and reduces the number of stenosis patients referred for...

ACC: AI-Based Video Biomarker Detects Aortic Stenosis Progression

MONDAY, April 8, 2024 -- A video-based artificial intelligence (AI) biomarker (Digital Aortic Stenosis [AS] Severity index [DASSi]) can detect severe AS development and...

FDA Issues Safety Alert for Impella Left-Sided Blood Pump

MONDAY, April 1, 2024 -- The U.S. Food and Drug Administration has issued a warning regarding a heart pump that could perforate a wall in the left ventricle if used...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.